CROSS COUNTRY HEALTHCARE INC (CCRN)

US2274831047 - Common Stock

17.57  -0.2 (-1.13%)

After market: 17.57 0 (0%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to CCRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.55. This target is 11.27% above the current price.
CCRN was analyzed by 15 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CCRN.
In the previous month the buy percentage consensus was at a similar level.
CCRN was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 17.5716.1619.3819.5525.20 - -8.03% 10.30% 11.27% 43.43%
Up and Down Grades
Date Firm Action Rating
2024-02-27 Barrington Research Maintains Outperform -> Outperform
2024-02-22 Benchmark Maintains Buy -> Buy
2024-02-22 Truist Securities Maintains Hold -> Hold
2023-12-06 JMP Securities Initiate Market Perform
2023-11-30 UBS Initiate Neutral
2023-11-29 Barrington Research Maintains Outperform -> Outperform
2023-11-03 Truist Securities Maintains Hold -> Hold
2023-11-03 Jefferies Downgrade Buy -> Hold
2023-10-05 Jefferies Maintains Buy -> Buy
2023-08-14 Barrington Research Maintains Outperform -> Outperform
2023-08-08 Credit Suisse Maintains Neutral -> Neutral
2023-06-26 William Blair Initiate Outperform
2023-06-01 Barrington Research Maintains Outperform -> Outperform
2023-05-05 Credit Suisse Maintains Neutral
2023-05-02 Truist Securities Maintains Hold
2023-03-10 Loop Capital Initiate Buy
2023-02-23 Benchmark Maintains Buy
2023-02-23 Credit Suisse Maintains Neutral
2022-11-07 Barrington Research Maintains Outperform
2022-10-05 Truist Securities Downgrade Buy -> Hold
2022-09-15 Benchmark Maintains Buy
2022-06-13 Benchmark Maintains Buy
2022-06-09 Credit Suisse Maintains Neutral
2022-02-24 Benchmark Maintains Buy
2022-01-27 Jefferies Upgrade Hold -> Buy
2021-08-16 Credit Suisse Maintains Neutral
2021-08-05 Benchmark Upgrade Hold -> Buy
2021-05-06 Benchmark Downgrade Buy -> Hold
2021-05-06 Credit Suisse Maintains Neutral
2021-02-25 Credit Suisse Maintains Neutral